Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder

Journal of Clinical Psychopharmacology

Volumn 17, Issue 4, 1997, Pages 261-266

  Pearlstein, Teri B ^a,d   Stone, Andrea B ^b   Lund, Sally A ^a   Scheft, Harriet ^c   Zlotnick, Caron ^a   Brown, Walter A ^a  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c Deaconess Waltham Hospital   (United States)

^d BUTLER HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; FLUOXETINE; PLACEBO;

ADULT; AGITATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DYSPHORIA; FATIGUE; FEMALE; HAMILTON SCALE; HEADACHE; HEART PALPITATION; HUMAN; INSOMNIA; LUTEAL PHASE; MENSTRUAL CYCLE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SEXUAL DYSFUNCTION; VERTIGO; XEROSTOMIA;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; MIDDLE AGED; PREMENSTRUAL SYNDROME; PSYCHIATRIC STATUS RATING SCALES;

EID: 0030796057     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199708000-00004     Document Type: Article

References (31)

1. Stone AB, Pearlstein TB, Brown WA. Fluoxetine in the treatment of late luteal phase dysphoric disorder. J Clin Psychiatry 1991;52: 290-3.
2. Menkes DB, Taghavi E, Mason PA, Spears GFS, Howard RC. Fluoxetine treatment of severe premenstrual syndrome. BMJ 1992; 305:346-7.
3. Wood SH, Mortola JF, Chan YF, Moossazadeh F, Yen SSC. Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study. Obstet Gynecol 1992;80: 339-44.
4. Eriksson E, Hedberg MA, Andersch B, Sundblad C. The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology 1995;12:167-76.
5. Steiner M, Steinberg S, Stewart D, Carter D, Berger C, Reid R, Grover D, Streiner D. Fluoxetine in the treatment of premenstrual dysphoria. N Engl J Med 1995;332:1529-34.
6. Yonkers KA, Halbreich U, Freeman E, Brown C, Pearlstein T. Sertraline in the treatment of premenstrual dysphoric disorder. Psychopharmacol Bull 1996;32:41-6.
7. Sundblad C, Modigh K, Andersch B, Eriksson E. Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial. Acta Psychiatr Scand 1992;85:39-47.
8. Sundblad C, Hedberg MA, Eriksson E. Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial. Neuropsychopharmacology 1993;9:133-45.
9. Rickels K, Freeman EW, Sondheimer S, Albert J. Fluoxetine in the treatment of premenstrual syndrome. Curr Ther Res 1990; 48:161-6.
10. Brandenberg S, Tuynman-Qua H, Verheij, R, Pepplinkhuizen L. Treatment of premenstrual syndrome with fluoxetine: an open study. Int Clin Psychopharmacol 1993;8:315-7.
11. Elks ML. Open trial of fluoxetine therapy for premenstrual syndrome. South Med J 1993;86:503-7.
12. Pearlstein TB, Stone AB. Long-term fluoxetine treatment of late luteal phase dysphoric disorder. J Clin Psychiatry 1994;55:332-5.
13. Freeman EW, Rickels K, Sondheimer SJ, Denis A, Pfeifer S, Weil S. Nefazodone in the treatment of premenstrual syndrome: a preliminary study. J Clin Psychopharmacol 1994;14:180-6.
14. Yonkers KA, Gullion C, Williams A, Novak K, Rush AJ. Paroxetine as treatment for premenstrual dysphoric disorder. J Clin Psychopharmacol 1996;16:3-8.
15. Freeman EW, Rickels K, Sondheimer SJ. Fluvoxamine for premenstrual dysphoric disorder: a pilot study. J Clin Psychiatry 1996;57[suppl 8]:56-60.
16. Harrison WM, Endicott J, Nee J. Treatment of premenstrual depression with nortriptyline: a pilot study. J Clin Psychiatry 1989; 50:136-9.
17. Taghavi E, Menkes DB, Howard RC, Mason PA, Shaw JP, Spears GFS. Premenstrual syndrome: a double-blind controlled trial of desipramine and methylscopolamine. Int Clin Psychopharmacol 1995;10:119-22.
18. Freeman EW, Rickels K, Sondheimer SJ, Wittmaack FM. Sertraline versus desipramine in the treatment of premenstrual syndrome: an open-label trial. J Clin Psychiatry 1996;57:7-11.
19. Spitzer RL, Williams JBW, Gibbon M, First MB. Instruction manual for the Structured Clinical Interview for DSM-III-R (SCID). New York, NY: New York State Psychiatric Institute, Biometric Research, 1988.
20. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
21. Endicott J, Spitzer RL, Fleiss JL, Cohen J. The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976;33:766-71.
22. Guy W. ECDEU assessment manual for psychopharmacology. Rockville, MD: National Institute of Mental Health, US Department of Health, Education and Welfare. Publication ADM 76-338, 1976:217-22.
23. SAS Institute Inc. SAS/STAT guide for personal computers, version 6, 4th ed. Cary, NC: SAS Institute, 1989.
24. Ascher JA, Cole JO, Colin JN, Feighner JP, Ferris RM, Fibiger HC, Golden RN, Martin P, Potter WZ, Richelson E, Sulser F. Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 1995;56:395-401.
25. Ferris RM, Cooper BR. Mechanism of antidepressant activity of bupropion [monograph]. J Clin Psychiatry 1993;11:2-14.
26. Charney DS, Delgado PL, Southwick SM, Krystal JH, Price LH, Heninger GR. Current hypotheses of the mechanism of antidepressant treatments: implications for the treatment of refractory depression. In: Amsterdam JD, ed. Refractory depression (Advances in neuropsychiatry and psychopharmacology series, vol. 2). New York: Raven Press, 1991:23-40.
27. Goodwin GM. How do antidepressants affect serotonin receptors? The role of serotonin receptors in the therapeutic and side effect profile of the SSRIs. J Clin Psychiatry 1996;57[suppl 4]: 9-13.
28. Potter WZ. Adrenoceptors and serotonin receptor function: relevance to antidepressant mechanisms of action. J Clin Psychiatry 1996;57[suppl 4]:4-8.
29. 1a receptor subsensitivity a trait marker for late luteal phase dysphoric disorder? A pilot study. Can J Psychiatry 1993;38:662-4.
30. Bancroft J, Cook A, Davidson D, Bennie J, Goodwin G. Blunting of neuroendocrine responses to infusion of L-tryptophan in women with premenstrual mood change. Psychol Med 1991;21: 305-12.
31. Menkes DB, Coates DC, Fawcett JP. Acute tryptophan depletion aggravates premenstrual syndrome. J Affect Disord 1994;32: 37-44.